FTC sues big pharmacy advantage managers more than insulin selling prices The company introduced action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing cost of daily life-conserving insulin medications. Elevance lowers steering on ‘unprecedented’ Medicaid troubles Executives reported th... https://aya-healthcare-address38372.dreamyblogs.com/30988886/healthcare-news-an-overview